Rare lephants
Screener

Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEF 14A Sep 1, 2017 DEF 14A
DEF 14A Aug 25, 2017 DEF 14A
PRE 14A Aug 10, 2017 PRE 14A
10-Q Aug 9, 2017 10-Q
8-K Aug 9, 2017 FORM 8-K
8-K Jul 25, 2017 FORM 8-K
SC 13G/A Jul 10, 2017
8-K Jun 7, 2017 FORM 8-K
4 May 16, 2017 OWNERSHIP DOCUMENT
10-Q May 10, 2017 FORM 10-Q
8-K May 10, 2017 8-K
8-K May 9, 2017 FORM 8-K
8-K Apr 18, 2017 FORM 8-K
8-K Apr 12, 2017 FORM 8-K
8-K Apr 12, 2017 FORM 8-K
DEFA14A Mar 29, 2017 DEFA14A
DEF 14A Mar 16, 2017 DEF 14A
10-K Mar 16, 2017 10-K
8-K Mar 16, 2017 FORM 8-K
PRE 14A Mar 6, 2017 PRE 14A
SC 13G/A Feb 23, 2017 SC 13G/A
8-K Feb 16, 2017 FORM 8-K
SC 13G/A Feb 15, 2017 SC 13G/A
SC 13G Feb 15, 2017 SC 13G
8-K Feb 14, 2017 FORM 8-K
← Newer Page 16 of 38 · 935 filings Older →